search
Back to results

Text-based Interventions to Promote COVID-19 Vaccinations

Primary Purpose

Covid19, Vaccines

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Patient MyChart Scheduling Link
Patient Educational Video
Enhanced Follow through Message
Sponsored by
University of California, Los Angeles
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Covid19, Vaccines focused on measuring COVID19, Vaccines, Text-messages, Patient Outreach, Behavioral Science

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion criteria:

All patients who satisfy the following criteria will be eligible to be included in our study:

  • They have a mobile phone number or SMS capable phone number in UCLA Health's database
  • They are eligible for receiving the COVID-19 vaccine at UCLA Health
  • They have not already scheduled an appointment the day before the scheduled time of text message
  • They are at or above 18 years old

Exclusion Criteria:

* Patients who already scheduled an appointment or obtained a COVID vaccine (at our collaborating health system or as documented in the California Immunization Registry (CAIR) https://cairweb.org/ ) by the time our text message is sent will be excluded from the analysis.

Sites / Locations

  • UCLA Health Department of Medicine, Quality Office

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

No Intervention

Experimental

Experimental

Experimental

Experimental

Arm Label

Holdout Arm

Simple Text Sub-arm

Simple Text + Video Sub-arm

Enhanced Text sub-Arm

Enhanced Text + Video Sub-arm

Arm Description

In the Holdout arm, patients will not receive text messages about COVID-vaccine.

In the Simple Text sub-arm, participants will not receive any additional information.

In the Simple Text+Video sub-arm, together with the appointment link, participants will also receive a link to a 2-minute video in the text message. The video contains information about the prevalence of COVID-19 and the effectiveness and safety of the COVID-19 vaccine.

In the Enhanced Text sub-arm, in addition to the appointment link, the text message will use enhanced language aimed at reducing psychological barriers that prevent patients from scheduling their appointment.

In the Enhanced Text+Video sub-arm, in addition to the appointment link, the text message will encourage patients to watch a 2-minute video (the same as in the Simple Text+Video sub-arm) and use enhanced language aimed at reducing patients' psychological barriers of following through on scheduling an appointment.

Outcomes

Primary Outcome Measures

First COVID-19 Vaccine Appointment Scheduled at UCLA Health
Whether patients schedule their vaccination appointment at UCLA Health within 6 days of receiving the text message (including the day of text message). Specifically, if t=the date of the text message (for the holdout arm, this refers to the date they would have received the text message had they not been assigned to the holdout arm), we will track vaccination appointments made by the end of t+5. While most people just make one appointment, a small percentage update their appointment time. We will have access to the latest few first-dose appointments people schedule by the time of data extraction.

Secondary Outcome Measures

First COVID-19 Vaccine obtained at UCLA Health
Whether patients get the first dose of COVID-19 vaccine at UCLA Health [time frame: 1 months from text message]
Time of obtaining the first COVID-19 vaccine at UCLA Health
The date when patients obtain the first dose of COVID-19 vaccine at UCLA Health [time frame: 1 months from text message]
First COVID-19 Vaccine obtained at UCLA Health or any organization reporting to CAIR
Whether patients obtain the first dose of COVID-19 vaccine at UCLA Health or another location reporting to the California Immunization Registry (CAIR). [time frame: 2 months from text message]
Time of obtaining the first COVID-19 at UCLA Health or another location reporting to CAIR
The date when patients obtain the first dose of COVID-19 vaccine at UCLA Health or another location reporting to the California Immunization Registry (CAIR) [time frame: 2 months from text message]

Full Information

First Posted
February 6, 2021
Last Updated
September 11, 2022
Sponsor
University of California, Los Angeles
Collaborators
Carnegie Mellon University
search

1. Study Identification

Unique Protocol Identification Number
NCT04800965
Brief Title
Text-based Interventions to Promote COVID-19 Vaccinations
Official Title
Text-based Interventions to Promote COVID-19 Vaccinations
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
January 31, 2021 (Actual)
Primary Completion Date
December 31, 2021 (Actual)
Study Completion Date
January 1, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Los Angeles
Collaborators
Carnegie Mellon University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study investigates whether and which type of text-based interventions affect the take-up of the COVID-19 vaccine.
Detailed Description
This study investigates whether and which type of text-based interventions affect the take-up of the COVID-19 vaccine. The primary research question is whether vaccine takeup can be boosted by a text-message intervention encouraging eligible patients to schedule a vaccination appointment. Patients, when becoming eligible for receiving the COVID-19 vaccine at UCLA Health, will be first notified about their eligibility and encouraged to schedule a vaccination appointment via one of the channels (email, voice call, or snail mail) depending on the contact information available to UCLA Health. Then patients eligible for the study will be randomized at a 1:4 ratio into a holdout control arm that does not receive a text message vs. a text-message arm that receives a text message. The secondary research question concerns which type of text message is more effective. To study this question, a nested 2x2 factorial design within the text-message arm will be used, where the two factors will be a) whether patients receive the link to an educational video specifically designed to shift patients' intentions to get the COVID-19 vaccine and b) whether the text message contains language aimed at encouraging patients to follow through on their intentions. In the Holdout arm: patients will not receive text messages about COVID-vaccine. In the text-message arm, all participants will receive a text message that invites them to schedule their vaccination appointment and includes a link to the appointment website In the Simple Text sub-arm, participants will not receive any additional information. In the Simple Text+Video sub-arm, together with the appointment link, participants will also receive a link to a 2-minute video in the text message. The video contains information about the prevalence of COVID-19 and the effectiveness and safety of the COVID-19 vaccine. In the Enhanced Text sub-arm, in addition to the appointment link, the text message will use enhanced language aimed at reducing psychological barriers that prevent patients from scheduling their appointment. In the Enhanced Text+Video sub-arm, in addition to the appointment link, the text message will encourage patients to watch a 2-minute video (the same as in the Simple Text+Video sub-arm) and use enhanced language aimed at reducing patients' psychological barriers of following through on scheduling an appointment. Patients will enter our study on a rolling basis, as they become eligible to get the vaccine (and if they fit our inclusion criteria). For the first batch of patients, those in the text-message arm will receive the text message within 4 -10 days after the initial invitation is sent (because the infrastructure of running this study is not ready until then). For subsequent batches of patients, they will be randomized and receive the text message (if they are not in the holdout arm) the first weekday after the initial communication goes out. We will measure a) whether patients schedule a COVID-19 vaccination appointment for the first dose and b) whether and when patients get the first dose of COVID-19 vaccine. Analysis: For the main analysis, we will run ordinary least squares regressions (OLS) with robust standard errors to predict the aforementioned outcome variables, except that we will use a Cox proportional hazards model with administrative censoring to predict time of obtaining the first COVID-19 vaccine. The significance level will be 0.05. Our primary hypothesis is that the text-message arm is significantly better than the holdout arm, so our primary analysis will compare the four text-message sub-arms all together with the holdout group. Our secondary analysis will investigate whether (1) the Simple Text sub-arm, (2) the two sub-arms containing a video, and (3) the two sub-arms containing enhanced language are better than the holdout arm. Furthermore, we will test (1) the effect of adding a video (vs. no video) to the text, (2) the effect of adding enhanced language (vs not adding enhanced language), and (3) whether the combination of video and enhanced language will outperform video alone or enhanced language alone. Our regressions will include the following control variables: Participant age Indicators for participant race/ethnicity (Black non-Hispanic, Hispanic, Asian non-Hispanic, white non-Hispanic, other/mixed, unknown; white non-Hispanic omitted) Whether the patient's preferred language is Spanish (which affects the language of text) Indicators for participant gender (male, female, other/unknown) Social vulnerability index score COVID19 Risk Factors Model Indicators for the batches of patients (patients will become eligible and receive initial communications in batches) As a robustness check, we will re-run the analysis as a logit regression (instead of an OLS regression) for binary outcome variables. We will explore the following moderators: Whether the patient is female or male Whether the patient is Black, Caucasian, Hispanic, or other Whether the patient's preferred language is Spanish Whether the patient is 65+ (including 65) or below 65 Patient's Social vulnerability index score Patient's COVID risk score Patient's population risk score Whether the patient is married (which is a proxy for whether they live together with family members) Whether or not the patient received a flu shot in either the 2019-2020 season or the 2020-2021 flu season prior to receiving our text message according to the patient's medical record The day of the week when the text message is sent to a patient. We will compare each day of the week. How strongly the participant's neighborhood is in favor of the Republican (vs. Democratic) Party if UCLA Health eventually agrees to provide de-identified address (e.g., zipcode). Plan for Early and Subsequent Analyses To inform policy as soon as possible, we plan to first assess the effects of our interventions in the early phase of vaccination outreach at UCLA Health. For this purpose, we plan to first analyze the data from the start of this RCT to the end of February. Given that we are using a 6-day time window for our primary dependent variable, we will examine data from patients who are randomized to either the holdout or text-message arm in this RCT before or on Feb 23, 2021. For this population, we will test: whether the text-message arm is significantly better than the holdout arm; whether the Simple Text sub-arm, the two subarms containing a video, and the two sub-arms containing enhanced language are better than the holdout arm the effect of adding a video (vs. no video) to the text the effect of adding enhanced language (vs not adding enhanced language) whether (1), (2), (3), and (4) varies based on whether patients received the flu vaccination in either the 2019-2020 season or the 2020-2021 season we will report the raw data for each sub-arm without conducting hypothesis testing across conditions that are not pre-registered in (1)-(4). In our early analysis, we will include controls that are available to us (it is possible that we do not have all of the controls described above at the time of early report). After all UCLA patients have been invited (or if vaccine distribution plan changes and UCLA Health no longer sends out text messages to patients at some point), we will do the following additional analyses: If the additional data collected afterwards exceeds 30K (which gives us 80% power to detect a 2pp difference between the holdout arm and the text message arm, assuming that holdout arm has a 50% baseline), then we will analyze the main effect of sending a text message (vs. holdout) and report the raw data for each sub-arm (to see if the patterns are qualitatively comparable with those in the early data). We will use the full sample (including the early data and subsequent data) to analyze (1) whether the combination of video and enhanced language will outperform video alone or enhanced language alone and (2) the aforementioned heterogeneous treatment effect.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Covid19, Vaccines
Keywords
COVID19, Vaccines, Text-messages, Patient Outreach, Behavioral Science

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
200000 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Holdout Arm
Arm Type
No Intervention
Arm Description
In the Holdout arm, patients will not receive text messages about COVID-vaccine.
Arm Title
Simple Text Sub-arm
Arm Type
Experimental
Arm Description
In the Simple Text sub-arm, participants will not receive any additional information.
Arm Title
Simple Text + Video Sub-arm
Arm Type
Experimental
Arm Description
In the Simple Text+Video sub-arm, together with the appointment link, participants will also receive a link to a 2-minute video in the text message. The video contains information about the prevalence of COVID-19 and the effectiveness and safety of the COVID-19 vaccine.
Arm Title
Enhanced Text sub-Arm
Arm Type
Experimental
Arm Description
In the Enhanced Text sub-arm, in addition to the appointment link, the text message will use enhanced language aimed at reducing psychological barriers that prevent patients from scheduling their appointment.
Arm Title
Enhanced Text + Video Sub-arm
Arm Type
Experimental
Arm Description
In the Enhanced Text+Video sub-arm, in addition to the appointment link, the text message will encourage patients to watch a 2-minute video (the same as in the Simple Text+Video sub-arm) and use enhanced language aimed at reducing patients' psychological barriers of following through on scheduling an appointment.
Intervention Type
Behavioral
Intervention Name(s)
Patient MyChart Scheduling Link
Intervention Description
Text message includes a link for patients to sign on to their patient portal (Epic MyChart) and schedule their COVID-19 vaccine appointment.
Intervention Type
Behavioral
Intervention Name(s)
Patient Educational Video
Intervention Description
Text message includes a link to a patient education video that aims to encourage patients to obtain the COVID-19 vaccine.
Intervention Type
Behavioral
Intervention Name(s)
Enhanced Follow through Message
Intervention Description
Text message includes information that will use enhanced language aimed at reducing psychological barriers that prevent patients from scheduling their appointment.
Primary Outcome Measure Information:
Title
First COVID-19 Vaccine Appointment Scheduled at UCLA Health
Description
Whether patients schedule their vaccination appointment at UCLA Health within 6 days of receiving the text message (including the day of text message). Specifically, if t=the date of the text message (for the holdout arm, this refers to the date they would have received the text message had they not been assigned to the holdout arm), we will track vaccination appointments made by the end of t+5. While most people just make one appointment, a small percentage update their appointment time. We will have access to the latest few first-dose appointments people schedule by the time of data extraction.
Time Frame
6 days
Secondary Outcome Measure Information:
Title
First COVID-19 Vaccine obtained at UCLA Health
Description
Whether patients get the first dose of COVID-19 vaccine at UCLA Health [time frame: 1 months from text message]
Time Frame
1 month from text message
Title
Time of obtaining the first COVID-19 vaccine at UCLA Health
Description
The date when patients obtain the first dose of COVID-19 vaccine at UCLA Health [time frame: 1 months from text message]
Time Frame
1 month from text message
Title
First COVID-19 Vaccine obtained at UCLA Health or any organization reporting to CAIR
Description
Whether patients obtain the first dose of COVID-19 vaccine at UCLA Health or another location reporting to the California Immunization Registry (CAIR). [time frame: 2 months from text message]
Time Frame
2 months from text message
Title
Time of obtaining the first COVID-19 at UCLA Health or another location reporting to CAIR
Description
The date when patients obtain the first dose of COVID-19 vaccine at UCLA Health or another location reporting to the California Immunization Registry (CAIR) [time frame: 2 months from text message]
Time Frame
2 months from text message

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria: All patients who satisfy the following criteria will be eligible to be included in our study: They have a mobile phone number or SMS capable phone number in UCLA Health's database They are eligible for receiving the COVID-19 vaccine at UCLA Health They have not already scheduled an appointment the day before the scheduled time of text message They are at or above 18 years old Exclusion Criteria: * Patients who already scheduled an appointment or obtained a COVID vaccine (at our collaborating health system or as documented in the California Immunization Registry (CAIR) https://cairweb.org/ ) by the time our text message is sent will be excluded from the analysis.
Facility Information:
Facility Name
UCLA Health Department of Medicine, Quality Office
City
Westwood
State/Province
California
ZIP/Postal Code
90095
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
29611455
Citation
Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing Vaccination: Putting Psychological Science Into Action. Psychol Sci Public Interest. 2017 Dec;18(3):149-207. doi: 10.1177/1529100618760521.
Results Reference
background
Citation
Haaland, I., Roth, C., & Wohlfart, J. (2020). Designing information provision experiments. CESifo Working Paper, No. 8406
Results Reference
background
PubMed Identifier
33315079
Citation
Volpp KG, Loewenstein G, Buttenheim AM. Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program. JAMA. 2021 Jan 12;325(2):125-126. doi: 10.1001/jama.2020.24036. No abstract available.
Results Reference
background

Learn more about this trial

Text-based Interventions to Promote COVID-19 Vaccinations

We'll reach out to this number within 24 hrs